INFUSE BONE GRAFT UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 03,05 report with the FDA on 2010-03-23 for INFUSE BONE GRAFT UNK manufactured by Medtronic Sofamor Danek Usa, Inc..

Event Text Entries

[14889258] It was reported that the patient presented with recurring unicameral bone cyst in the proximal femur. Through an earlier incision, the patient was treated with open curettage of the left proximal femur, which was then packed with a mixture of left iliac crest bone graft, demineralized bone matrix, and 12 mg of rhbmp-2 delivered on a collagen sponge matrix. The patient had an unremarkable hospital stay and was discharged 2 days later. Four days after the procedure, the patient was presented at the emergency department with left leg pain and swelling. Patient appeared in no acute distress, with normal vital signs , neurovascular function, range of motion, and blood panels. Her left thigh was seen to be at least twice the size of her right thigh. Area was swollen and mildly tight but compartments were soft and remained easily compressible. Superficially, her incision appeared to be healing well with no surrounding erythema, purulent material, or tenderness. Radiographs showed evidence of significant swelling in soft tissues medially and laterally, although no new bony or hardware abnormalities were noted. The patient was admitted to the hospital for observation with discharge the following day because of the decreased swelling. Follow-up three days later revealed a slight decrease in left thigh swelling. At her most recent follow-up evaluation, 4 months later, the patient continued to heal well with her symptoms fully resolved.
Patient Sequence No: 1, Text Type: D, B5


[15521546] (b) (4). Literature article citation: macdonald et al. Exaggerated inflammatory response after use of recombinant bone morphogenic protein in recurrent unicameral bone cyst. Pediatric orthopedics 2010; (vol 30. No. 2). A review of the certificates of analysis and packing list for the infuse bone graft was not possible without additional device information. Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation. Therefore, we are unable to determine the definitive cause of the reported event.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1030489-2010-00389
MDR Report Key1639930
Report Source03,05
Date Received2010-03-23
Date of Report2010-02-26
Date of Event2010-03-01
Report Date2010-02-26
Date Mfgr Received2010-02-26
Date Added to Maude2010-03-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactCHAD ASHTON
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal38132
Manufacturer Phone9013963133
Manufacturer G1MEDTRONIC SOFAMOR DANEK USA, INC.
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38118
Manufacturer CountryUS
Manufacturer Postal Code38118
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINFUSE BONE GRAFT
Generic NameINFUSE BONE GRAFT
Product CodeMPW
Date Received2010-03-23
Model NumberNA
Catalog NumberUNK
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeNA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC SOFAMOR DANEK USA, INC.
Manufacturer Address4340 SWINNEA RD. MEMPHIS TN 38118 US 38118


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2010-03-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.